SHPH

Shuttle Pharmaceuticals Holdings, Inc.

There isn't enough reported data to score SHPH yet.

SHPH Fundamentals

MetricStatus
Unavailable
Weak
Unavailable
Unavailable

SHPH's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.

SHPH PE Valuation

SHPH has no meaningful PE right now: it lost money over the past year.

SHPH Forward outlook

There aren't enough analyst estimates for SHPH to show an outlook.

SHPH Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $4.76 on Nov 12.

There is not enough scenario data to assess SHPH's risk to reward.

SHPH Earnings Per Share

Q4 2023: $-879.76Q1 2024: $-947.26Q2 2024: $-887.26Q3 2024: $-1,064.76Q4 2025: $-143.60Q1 2026: $-72.90Q2 2026: $-43.10
Q4 2023: $-879.76Q1 2024: $-947.26Q2 2024: $-887.26Q3 2024: $-1,064.76Q4 2025: $-143.60Q1 2026: $-72.90Q2 2026: $-43.10

SHPH lost $43.10 per share over the past year, a smaller loss than the year before.

SHPH Quarterly Revenue

Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --
Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --

SHPH Free Cash Flow

Q3 2023: --Q4 2023: โˆ’$1MQ1 2024: โˆ’$1MQ2 2024: โˆ’$1MQ3 2024: --Q4 2024: --Q1 2025: โˆ’$3MQ2 2025: โˆ’$3MQ3 2025: โˆ’$3MQ4 2025: โˆ’$973,012Q1 2026: โˆ’$2MQ2 2026: โˆ’$567,640
Q3 2023: --Q4 2023: โˆ’$1MQ1 2024: โˆ’$1MQ2 2024: โˆ’$1MQ3 2024: --Q4 2024: --Q1 2025: โˆ’$3MQ2 2025: โˆ’$3MQ3 2025: โˆ’$3MQ4 2025: โˆ’$973,012Q1 2026: โˆ’$2MQ2 2026: โˆ’$567,640
QuarterFree cash flowYoY
Q2 2026-$567.6K+$2.8M
Q1 2026-$2.4M+$109.6K
Q2 2025-$3.4M-$2M
Q1 2025-$2.5M-$1.3M
Q2 2024-$1.4M+$246.7K
Q1 2024-$1.2M+$98.9K
Q4 2023-$1.1M-$382.3K

SHPH has burned cash in almost every quarter: โˆ’$7M over the past year, against โˆ’$9M the year before.

SHPH Total Shares

Q3 2023: 7,872Q4 2023: 7,465Q1 2024: 8,303Q2 2024: 8,420Q3 2024: 9,537Q1 2025: 40,196Q2 2025: 112,605Q3 2025: 223,365Q1 2026: 503,157Q2 2026: 1M
Q3 2023: 7,872Q4 2023: 7,465Q1 2024: 8,303Q2 2024: 8,420Q3 2024: 9,537Q1 2025: 40,196Q2 2025: 112,605Q3 2025: 223,365Q1 2026: 503,157Q2 2026: 1M
PeriodChange %Net change
Quarterly+102%+512K shares
1 year+2426%+975K shares
3 years+19876%+1M shares

SHPH has 1M diluted shares, up 2426% from a year ago.

SHPH Net Leverage

SHPH's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

SHPH Weekly Momentum

MetricValueStatus
RSI42.5Neutral
Stochastic79.0Neutral

SHPH's weekly RSI is 42 (neutral) and its Stochastic is 79 (neutral).

SHPH PE vs Healthcare Sector

SHPH has no meaningful PE right now: it lost money over the past year.

SHPH Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$4.872.3% below
20 week MA$4.0617% above
50 week MA$8.3243% below
100 week MA$44.089% below
200 week MA$707.399% below

SHPH's trend is mixed: it's above one of its five weekly moving averages, and 99% below its 200-week average.

SHPH Yearly ROI

YearStart priceEnd priceROI
2022$29,800.0$4,200.0-86%
2023$4,200.0$910.0-78%
2024$910.0$185.3-80%
2025$185.3$18.7-90%
2026 YTD$18.7$4.76-75%

SHPH has finished every year since 2022 lower, and it's down 75% so far in 2026.

Give your agent the market.

Get API key